Latanoprost NDC 65862-872

NDC codes

FDA NDC Directory

Product NDC (as listed)65862-872Labeler and product segments. Claims need a package NDC.

Product NDC at billing width65862-0872Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
65862-872-25	65862087225	1 BOTTLE in 1 CARTON (65862-872-25) / 2.5 mL in 1 BOTTLEMarketed from Sep 3, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Latanoprost
Generic name (nonproprietary): latanoprost
Active ingredients: Latanoprost — 50 ug/mL
Dosage form: Solution/ drops
Route: Ophthalmic
Labeler: Aurobindo Pharma Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 206519
Marketing start: Sep 3, 2019
Listing expires: Dec 31, 2026
Identifiers: Product ID 65862-872_cad9da15-f479-4b42-9d22-02c3f7dab1baSPL ID cad9da15-f479-4b42-9d22-02c3f7dab1baSPL set ID 19cdfef0-b770-4758-8f59-1769e4b6119cRxCUI 314072UNII 6Z5B6HVF6OUPC 0365862872258

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N465862087225 followed by a unit qualifier and the quantity

Package 65862-0872-25. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 27, 2024.

Indications (excerpt from the label)

Latanoprost ophthalmic solution is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. Latanoprost ophthalmic solution is a prostaglandin F 2α analogue indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)